At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Prostaglandins; Tocolytics
- Mechanism of Action Dinoprostone agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
Most Recent Events
- 05 Mar 2001 No-Development-Reported for Preterm labour in United Kingdom (Unknown route)
- 22 Jan 2001 Glaxo Wellcome has merged with SmithKline Beecham to form GlaxoSmithKline